Information Journal Paper
APA:
Copy. (2017). Capecitabine with mitomycin reduces acute hematologic toxicity and treatment delays in patients undergoing definitive chemoradiation using intensity modulated radiation therapy for anal cancer. International Journal of Radiation Oncology, Biology, Physics, 98(5), 1087-1095. SID. https://sid.ir/paper/730852/en
Vancouver:
Copy. Capecitabine with mitomycin reduces acute hematologic toxicity and treatment delays in patients undergoing definitive chemoradiation using intensity modulated radiation therapy for anal cancer. International Journal of Radiation Oncology, Biology, Physics[Internet]. 2017;98(5):1087-1095. Available from: https://sid.ir/paper/730852/en
IEEE:
Copy, “Capecitabine with mitomycin reduces acute hematologic toxicity and treatment delays in patients undergoing definitive chemoradiation using intensity modulated radiation therapy for anal cancer,” International Journal of Radiation Oncology, Biology, Physics, vol. 98, no. 5, pp. 1087–1095, 2017, [Online]. Available: https://sid.ir/paper/730852/en